Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02919618 · ClinicalTrials.gov registry record · Phase 1
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT02919618 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 19 participants.
The verdict
NCT02919618, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation (ENCORE) for Treatment of Ventricular Tachycardia
Interventions
- RADIATION stereotactic body radiotherapy (SBRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-07 |
| Est. Completion | 2024-01-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02919618
The ClinicalTrials.gov registry entry for NCT02919618 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which stereotactic body radiotherapy (SBRT) is the first listed.
NCT02919618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02919618 about?
NCT02919618 is a clinical study titled "Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia". Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation (ENCORE) for Treatment of Ventricular Tachycardia
What is the current status of trial NCT02919618?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2016-07. Estimated completion is 2024-01-01.
What interventions are being tested in trial NCT02919618?
The interventions under investigation include: stereotactic body radiotherapy (SBRT) (RADIATION).
Who is sponsoring clinical trial NCT02919618?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.